Epidemiology and antibiotic susceptibility of bacteria causing skin and soft tissue infections in the USA and Europe: a guide to appropriate antimicrobial therapy
Mark E. Jones(Basilea Pharmaceutica (Switzerland)), Dilip Nathwani(Ninewells Hospital), Deborah C. Draghi, Clyde Thornsberry, James A. Karlowsky(University of Manitoba), Daniel F. Sahm(Micro Focus (United States))
Cited by 230
Related Papers
Clinical and economic burden of community-acquired pneumonia among adults in Europe
|Thorax|2010|1.1k
Prevalence in the United States of <i>aac(6</i> ′ <i>)</i> - <i>Ib</i> - <i>cr</i> Encoding a Ciprofloxacin-Modifying Enzyme
|Antimicrobial Agents and Chemotherapy|2006|749
Multiple-Drug Resistant Enterococci: The Nature of the Problem and an Agenda for the Future
|Emerging infectious diseases|1998|732
Laboratory-based surveillance of current antimicrobial resistance patterns and trends among Staphylococcus aureus: 2005 status in the United States
|Annals of Clinical Microbiology and Antimicrobials|2006|384
Trends in Antimicrobial Resistance among Urinary Tract Infection Isolates of <i>Escherichia coli</i> from Female Outpatients in the United States
|Antimicrobial Agents and Chemotherapy|2002|369